Chemical Compound
Lopinavir phenoxyacetamide
CAS Registry Number
192725-49-8
Primary Record
Lopinavir phenoxyacetamide
- In stock
- 7,560 g
- Purity
- 98.9 %
- CAS
- 192725-49-8
Compound Identifiers & Properties
- CAS
- 192725-49-8
- PubChem CID
- 10961286
- SMILES
- CC1=C(C(=CC=C1)C)OCC(=O)N[C@@H](CC2=CC=CC=C2)[C@H](C[C@H](CC3=CC=CC=C3)N)O
- Canonical SMILES
- Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@@H](N)Cc1ccccc1
Names & Synonyms
- Lopinavir phenoxyacetamide
- 192725-49-8
- Lopinavir EP Impurity E
- N-((2S,3S,5S)-5-Amino-3-hydroxy-1,6-diphenylhexan-2-yl)-2-(2,6-dimethylphenoxy)acetamide
- Lopinavir impurity E [EP]
- S21JGQ154U
- UNII-S21JGQ154U
- RefChem:1090685
- SCHEMBL672415
- DTXSID10172868
- DTXCID3095359
- CTK0H1472
- LWXUXIDLCWPHIW-GSDHBNRESA-N
- ANW-69586
- MFCD09835124
- ZINC22058115
- AKOS015909344
- AC-8897
- AN-5930
- CS-O-30829
- RL02428
- CID10961286
- AJ-80859
- (2S,3S,5S)-2-(2,6-DIMETHYLPHENOXYACETYL)AMINO-3-HYDROXY-5-AMINO-1,6-DIPHENYLHEXANE
- LOPINAVIR IMPURITY E [EP IMPURITY]
- RT-005438
- J1.543.457K
- N-[(1S,2S,4S)-4-AMINO-2-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL]-2-(2,6-DIMETHYLPHENOXY)ACETAMIDE
- C15200
- Lopinavir impurity, lopinavir phenoxyacetamide- [USP]
- N-[(2S,3S,5S)-5-AMINO-3-HYDROXY-1,6-DIPHENYLHEXAN-2-YL]-2-(2,6-DIMETHYLPHENOXY)ACETAMIDE
- I14-33398
- N-((1S,2S,4S)-4-Amino-1-benzyl-2-hydroxy-5-phenylpentyl)-2-(2,6-dimethylphenoxy)acetamide
- Q27288469
- Acetamide, N-((1S,2S,4S)-4-amino-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)-2-(2,6-dimethylphenoxy)-
- Acetamide, N-[(1S,2S,4S)-4-amino-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-2-(2,6-dimethylphenoxy)-
- LOPINAVIR IMPURITY, LOPINAVIR PHENOXYACETAMIDE- [USP IMPURITY]
- (2S, 3S, 5S) -2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-amino-1,6-diphenylhexane
- (2S, 3S, 5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-amino-1,6-diphenylhexane
- (2S,3S,5S) -2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-amino-1,6-diphenylhexane
- Acetamide, N-[(1S,2S,4S)-4-amino-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-2-(2,6-dimethylphenoxy)-; Acetamide, N-[4-amino-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-2-(2,6-dimethylphenoxy)-, [1S-(1R*,2R*,4R*)]-; N-[(1S,2S,4S)-4-Amino-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-2-(2,6-dimethylphenoxy)acetamide; (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl)amino-3-hydroxy-5-amino-1,6-diphenylhexane; Lopinavir Imp. E (EP); N-[(2S,3S,5S)-5-Amino-3-hydroxy-1,6-diphenylhexan-2-yl]-2-(2,6-dimethylphenoxy)acetamide; Lopinavir phenoxyacetamide
- N-[(1S,2S,4S)-1-Benzyl-2-hydroxy-4-amino-5-phenylpentyl]-2-(2,6-dimethylphenoxy)acetamide
- N-[(1S,2S,4S)-4-amino-1-benzyl-2-hydroxy-5-phenyl-pentyl]-2-(2,6-dimethylphenoxy)acetamide
- N-[(1S,2S,4S)-4-amino-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]-2-(2,6-dimethylphenoxy) Acetamide
- N-[(2S,3S,5R)-5-amino-3-hydroxy-1,6-diphenyl-hexan-2-yl]-2-(2,6-dimethylphenoxy)acetamide